pharma · Glioblastoma, IDH-wildtype · SHPH
Shuttle Pharmaceuticals Holdings
Shuttle Pharmaceuticals is a pharma organization headquartered in Rockville, USA. It trades on NYSE under ticker SHPH. Primary therapeutic focus areas include Glioblastoma, IDH-wildtype. NovaPharmaNews links 1 clinical p
Rockville, USA HQ
2012 Founded
5 Employees
Public company Type
SHPH · NYSE Ticker
Company details
- Status
- Public
- HQ
- Rockville, USA
- Founded
- 2012
- Employees
- 5
- Programs
- 1
- Drugs
- 1
- Patents
- 9
Ropidoxuridine
Phase 2 · small molecule · Glioblastoma, IDH-wildtype
Ropidoxuridine for Glioblastoma, IDH-wildtype is a Phase 2 program (small_molecule) at Shuttle Pharmaceuticals Holdings with 1 ClinicalTrials.gov record(s).
Internal code S22-11168
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Shuttle Pharmaceuticals Holdings
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Glioblastoma, IDH-wildtype
- Status
- terminated
- Trials
- 1